Notice of Clarification for AIDS Dates for RFA-HL-17-015 "Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases (R21)"
Notice NOT-HL-18-582 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 7, 2018 Category: Research Source Type: funding

Connections for Cardiovascular Health
Provides grants to nonprofit organizations working to improve cardiovascular health at the community level. Geographic coverage: Nationwide -- AstraZeneca Healthcare Foundation (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - February 6, 2018 Category: American Health Source Type: funding

Notice Announcing Frequently Asked Questions (FAQs) for PAR-18-577, New Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01 Clinical Trials Not Allowed)
Notice NOT-HL-18-590 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 1, 2018 Category: Research Source Type: funding

Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-19-002 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this National Heart, Lung, and Blood Institute R25 program is to support educational activities that complement and/or enhance the training of junior faculty from backgrounds underrepresented in the biomedical sciences so as to meet the nations biomedical, behavioral and clinical research needs and enhance the diversity of its workforce. The major intent of this Research Education Program (R25) is to establ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 30, 2018 Category: Research Source Type: funding

Notice of Expiration of RFA-HL-17-012 "Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood, and Sleep Technologies with Small Commercial Markets (R44)"
Notice NOT-HL-18-584 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 24, 2018 Category: Research Source Type: funding

Notice of Correction of Key Dates for PAR-17-004 " Secondary Analyses of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)"
Notice NOT-HL-18-583 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 24, 2018 Category: Research Source Type: funding

NHLBI Announces Webinar for PAR-18-577, New Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01 - Clinical Trial Not Allowed)
Notice NOT-HL-18-587 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 23, 2018 Category: Research Source Type: funding

Correction to the Application Forms Package issued for PAR-17-338 "Continuation of Existing Grant Based Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01-Clinical Trials Not Allowed)"
Notice NOT-HL-18-581 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 16, 2018 Category: Research Source Type: funding

NHLBI Announces Plan to Fund a Framingham Heart Study Exam
Notice NOT-HL-17-572 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 12, 2018 Category: Research Source Type: funding

New Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01 - Clinical Trials Not Allowed)
Funding Opportunity PAR-18-577 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite grant applications to establish new and innovative epidemiology cohort studies that will prospectively follow at least 2,000 participants and are designed to study a wide range of research hypotheses related to heart, lung, blood, and/or sleep phenotypes. Through this FOA, the National Heart, Lung, and Blood Institute (NHLBI) will support activities required to establish a new cohort, including identification and recruitment of cohort participants, detailed baseline data col...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 12, 2018 Category: Research Source Type: funding

Strategies to Increase Delivery of Guideline-Based Care to Populations with Health Disparities (R01 Clinical Trial Optional)
Awards funding for innovative, multi-level studies to test systems, infrastructures, and strategies that will accelerate the adoption of guideline-based recommendations into clinical care relevant to heart, lung, blood diseases, and sleep disorders. Vulnerable populations include medically underserved individuals, racial and ethnic minorities, low income groups, and rural-dwelling patients. Geographic coverage: Nationwide -- National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - December 12, 2017 Category: American Health Source Type: funding

Studies in Neonatal and Pediatric Resuscitation (R01 Clinical Trial Optional)
Funding Opportunity PA-18-485 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to stimulate research on a wide range of topics related to neonatal and pediatric resuscitation. Possible topics may include, but are not limited to: fetal-neonatal transitional cardiovascular and pulmonary physiology, optimizing steps of resuscitation, management of third stage of labor and its effect on the fetus, resuscitation of children with malformations, effect of resuscitation on long-term outcomes and post-resuscitation practices. Proposals can include epidemiological studies,...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 11, 2017 Category: Research Source Type: funding

Studies in Neonatal and Pediatric Resuscitation (R03 - Clinical Trial Optional)
Funding Opportunity PA-18-491 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to stimulate research on a wide range of topics related to neonatal and pediatric resuscitation. Possible topics may include, but are not limited to: fetal-neonatal transitional cardiovascular and pulmonary physiology, optimizing steps of resuscitation, management of third stage of labor and its effect on the fetus, resuscitation of children with malformations, effect of resuscitation on long-term outcomes and post-resuscitation practices. Proposals can include epidemiological studies,...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 11, 2017 Category: Research Source Type: funding

Notice of Change of Key Dates for RFA-HL-17-015 "Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases (R21)"
Notice NOT-HL-17-567 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 6, 2017 Category: Research Source Type: funding

NHLBI Clinical Trial Pilot Studies (R34 - Clinical Trial Optional)
Funding Opportunity PAR-18-463 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is to support studies that are essential, yet also sufficient, for investigators to make definitive decisions about the designs of important clinical trials within NHLBI's mission, the prevention and treatment of heart, lung, blood, and sleep disorders. This mechanism may be used to test the feasibility of novel and efficient (pragmatic) trial designs, as well as determine the feasibility of an intervention, intervention parameters, subject availability, or other information essential to complete the d...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 1, 2017 Category: Research Source Type: funding